ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Fallers
Down 43% in a year: 2 ASX 200 shares to buy 'well below fair value'
Growth Shares
Analysts expect market-beating returns from these ASX growth shares
Broker Notes
3 winners and 3 losers from ASX reporting season
52-Week Lows
Why is everyone talking about Resmed shares and Ozempic?
Blue Chip Shares
2 quality ASX 200 blue chip shares to buy and hold: Bell Potter
Cheap Shares
Why today's cheap ASX shares could double my money during the next bull market
Broker Notes
Brokers name 3 ASX shares to buy now
Healthcare Shares
ResMed shares just hit a new 52-week low. Should I snap some up?
Cheap Shares
'Buying opportunity': 2 ASX 200 shares to buy for dirt cheap right now
Opinions
Why I think this ASX healthcare share is starting to get ridiculously oversold
Growth Shares
2 ASX growth shares with 30% upside: analysts
Share Market News
Here are the top 10 ASX 200 shares today
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
